MHRA

News

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

Views & Analysis

How can the UK improve in clinical research? A biotech persp...

The UK is a great place for early-stage research – but NHS red tape and market access remain major barriers.

Views & Analysis

Pharma and med device sectors being forced into Hard Brexit ...

Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?

News

London, UK - January 8, 2015: City of London panorama includes high street with office and governments buildings

Orchard’s gene therapy gains UK ‘promising innovative medici...

A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy.

News

NHS supremo hails Alexion and Roche deals, but defends budge...

Simon Stevens hails success in negotiating with pharma companies on price and data, and has defended NHS England’s record in promoting innovative medicines.

News

UK medicines agency set to lose lucrative EMA work post-Brex...

Agency already working on how to share post-Brexit workload.

BI drug named Promising Innovative Medicine in mesothelioma

How can the UK improve in clinical research? A biotech persp...

Pharma and med device sectors being forced into Hard Brexit ...

Orchard’s gene therapy gains UK ‘promising innovative medici...

NHS supremo hails Alexion and Roche deals, but defends budge...

UK medicines agency set to lose lucrative EMA work post-Brex...

Bayer gets swift review for Kerendia in type 1 diabetes

Discover a new era of healthcare panel engagement: Grounded ...

MHRA

Editor's Picks